http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020323771-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_604e07c32377cab416660b10fd8f494c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
filingDate 2020-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4875fcfb03230a8f0e72a9ba3ff37555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7611359cb5c9567099ec672a84b5a82
publicationDate 2020-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020323771-A1
titleOfInvention Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin
abstract There is disclosed a method for administration of a formulation of resiniferatoxin (RTX) to provide cardiac sympathetic afferent denervation when applied in an amount and concentration sufficient to chemically denervate vanilloid 1 receptor (TRPV1)-expressing CSAR (cardiac sympathetic afferent reflex) afferents. There is further disclosed a method for treating heart failure or hypertension and its related indications selected from the group consisting of increased sympatho-excitation, cardiac hypertrophy, increased left ventricular end diastolic pressure (LVEDP), lung edema, and combinations thereof, comprising administering an effective amount of RTX directly to a tissue site selected from the group consisting of epicardium, a T1-T4 dorsal root ganglion and intrathecally to the T1-T4 region of the spinal column.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254659-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447444-B1
priorityDate 2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155207429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66584305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID439245756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57090162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7057995

Total number of triples: 48.